US Patent 7329752 Carbamate compounds as 5-HT
Patent 7329752 was granted and assigned to Theravance on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Adam A. Goldblum0
Daniel D. Long0
Daniel Marquess0
Paul R. Fatheree0
Seok-Ki Choi0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+139 characters)
Article
Patent abstract
The invention provides novel benzoimidazolone-carboxamide-derived carbamate 5-HT4 receptor agonist compounds of formula (I):
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07329752 Carbamate compounds as 5-HT US Patent 7329752 Carbamate compounds as 5-HT
Infobox
Patent Number
073297520
Patent Number
73297520
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073297520
Date of Patent
February 12, 2008
0Patent Application Number
116028880
Date Filed
November 21, 2006
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07329752 Carbamate compounds as 5-HT
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07329752
Date of patent
February 12, 2008
Patent application number
11602888
Date Filed
November 21, 2006
Patent primary examiner
Find more entities like US Patent 7329752 Carbamate compounds as 5-HT
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
